Jazz Pharmaceuticals (JAZZ) Stock Price
$136 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
5 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Jazz Pharmaceuticals, AI stock picks, stock alerts and much more.
JAZZ AI Stock Analysis
AI stock analysis for JAZZ is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Jazz Pharmaceuticals (JAZZ) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Jazz Pharmaceuticals (JAZZ) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Jazz Pharmaceuticals (JAZZ), currently trading at $136, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About JAZZ
-
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally.
-
Symbol
JAZZ
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
8.2B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
JAZZ Alternative Data
Web Traffic
Jazz Pharmaceuticals receives an estimated 92022 monthly visitors to jazzpharma.com.
-
Web Traffic
92022
-
Change from Previous Month
31.1%
-
3 Month Change
14.8%
-
YoY Change
14.8%
News Mentions
Jazz Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
50%
-
3 Month Change
0%
Reddit Mentions
Jazz Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Jazz Pharmaceuticals has 3,542 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
3542
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Job Postings
Jazz Pharmaceuticals has an estimated 62 open job postings, which is down -1.6% over the last month.
-
Job Postings
62
-
Daily Change
10.7%
-
1 Month Change
1.6%
-
3 Month Change
10.1%
-
YoY Change
10.1%
LinkedIn Employees
According to LinkedIn, Jazz Pharmaceuticals has 3,405 employees, up by 0.4% over the last month.
-
LinkedIn Employees
3405
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Business Outlook
-
Business Outlook
37
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
JAZZ Financials
JAZZ Key Metrics
-
Total Revenue
$1.1B
-
Net Income
$215.1M
-
Earnings per Share
$3.5
-
Free cash flow
$412.7M
-
EBITDA
$260.2M
-
EBITDA Ratio
0.246652
-
Total Assets
$12.3B
JAZZ 2-year Revenue & Income
JAZZ 2-year Free Cash Flow
JAZZ Technicals
JAZZ SMA
JAZZ RSI
FAQ
What's the current price of Jazz Pharmaceuticals (JAZZ) Stock?
The price of an Jazz Pharmaceuticals (JAZZ) share is $136.
What's the market cap of Jazz Pharmaceuticals?
The current market cap of Jazz Pharmaceuticals is 8.2B.
Should I buy or sell JAZZ?
Jazz Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Jazz Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Jazz Pharmaceuticals a good investment?
The current analysis of Jazz Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Jazz Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Jazz Pharmaceuticals (JAZZ) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Jazz Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Jazz Pharmaceuticals (JAZZ) that investors often compare it to?
Jazz Pharmaceuticals (JAZZ) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Jazz Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Jazz Pharmaceuticals' stock price to be around $140.4 in 2026. Starting from the current price of $136, this represents a 3.2% change in price, indicating a neutral outlook for the stock.
How to buy Jazz Pharmaceuticals (JAZZ) Stock?
Jazz Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Jazz Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.